Monitor HCA's 2026 EBITDA performance and quality metrics, as these will determine executive compensation payouts. The board retirement is routine and unlikely to affect governance or strategy.
Price Chart
Executive Summary
HCA Healthcare adopted its 2026 Executive Officer Performance Excellence Program (PEP), establishing cash-based incentive awards for executives tied to EBITDA (80%) and quality metrics (20%). The filing also announced the retirement of board member Robert J. Dennis effective April 23, 2026. No financial results or material operational changes were disclosed.
Key Facts
- HCA adopted the 2026 Executive Officer Performance Excellence Program (PEP) on February 24, 2026
- PEP awards are cash-based and tied to 80% EBITDA targets and 20% quality metrics (infections, complications, care experience)
- Target award opportunities: 175% of base salary for CEO Samuel Hazen, 125% for CFO Michael Marks and COO Jon Foster, 100% for other named executives
- No payment is made for quality metrics if actual EBITDA is below 90% of target
- Board member Robert J. Dennis will retire effective April 23, 2026, after not standing for re-election
Financial Impact
No immediate financial impact disclosed; potential future cash compensation expense tied to 2026 performance
Risk Factors
- Executive compensation could increase significantly if EBITDA and quality targets are exceeded
- No quality payouts if EBITDA falls below 90% of target, creating misalignment risk in challenging financial conditions
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-071880 |
| Document: d945112dex101.htm | 0001193125-26-071880 |
| Document: 0001193125-26-071880-index-headers.html | 0001193125-26-071880 |
| Document: 0001193125-26-071880-index.html | 0001193125-26-071880 |
| Document: 0001193125-26-071880.txt | 0001193125-26-071880 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 24, 2026 10w ago | 8-K | $382.19 $429.19 | ▲ +12.30% | ▲ +8.67% | $426.69 (+11.64%) |
Jul 14, 2026 11w ago | 8-K | $363.60 $411.44 | ▼ −13.16% | ▼ −10.67% | $426.69 (−17.35%) |
Jun 18, 2026 15w ago | 8-K | $375.17 $385.74 | ▲ +2.82% | ▲ +2.28% | $426.69 (+13.73%) |
Apr 27, 2026 22w ago | 8-K | $431.48 $392.42 | ▼ −9.05% | ▼ −14.52% | $426.69 (−1.11%) |
Apr 27, 2026 22w ago | Court Ruling | $445.70 $392.48 | ▼ −11.94% | ▼ −16.87% | $426.69 (−4.26%) |
Apr 24, 2026 23w ago | 8-K | $432.55 $392.56 | ▼ −9.25% | ▼ −13.27% | $426.69 (−1.36%) |
Mar 13, 2026 29w ago | DEFA14A | $525.04 $496.74 | ▼ −5.39% | ▼ −9.17% | $426.69 (−18.73%) |
Feb 25, 2026 31w ago | 8-K | $525.78 $479.78 | ▼ −8.75% | ▼ −2.35% | $426.69 (−18.85%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access